1 | Age- and gender-specific rates of institutionalization are derived from 2009 and remain unchanged between 2009 and 2025. The rational for this assumption is the uncertainty of further development of age- and gender-specific institutionalisation rates and the limited impact of such changes on the absolute number of community-dwelling persons. |
2 | Age- and gender-specific fracture rates derived from routine data by AOK Bavaria applies to all other community-dwelling older persons living in Bavaria since more than 50 % of persons aged 65 and older are covered by this insurance. |
3 | Participation in FPE and bisphosphonate treatment between 2004 and 2009 were not considered, i.e. assumed to be 0 % since there is no valid data on true participation and treatment rates available. |
4 | Age- and gender-specific fracture rates derived from 01.01.2004 to 30.06.2009 remain unchanged until 2025. |
5 | Effect size of Fall Prevention Exercise (FPE) is based on a meta-analysis with ‘reduction of any fracture rate’ as endpoint. Effect size of the reduction of femoral fractures is identical since there is no other data available. |
6 | FPE targets only persons aged 70 to 89 years. |
7 | Effect size is constant over time for both interventions. |
8 | Age- and gender-specific distribution of osteoporosis remains unchanged until 2025. |
9 | Bisphosphonate treatment is limited to people with osteoporosis based on BMD values (T-score -2.5). Concomitant risk factors modifying the threshold for treatment are not considered. |
10 | The effect size of bisphosphonates in men is identical to that in women since data on effect size in men is rare. |